CONQUERING CANCER. THAT'S IN OUR DNA. Trademark

Trademark Overview


On Tuesday, July 1, 2014, a trademark application was filed for CONQUERING CANCER. THAT'S IN OUR DNA. with the United States Patent and Trademark Office. The USPTO has given the CONQUERING CANCER. THAT'S IN OUR DNA. trademark a serial number of 86325593. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 4, 2017. This trademark is owned by CTI BIOPHARMA CORP.. The CONQUERING CANCER. THAT'S IN OUR DNA. trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens

Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders

Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classificat...
conquering cancer. that's in our dna.

General Information


Serial Number86325593
Word MarkCONQUERING CANCER. THAT'S IN OUR DNA.
Filing DateTuesday, July 1, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 4, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens
Goods and ServicesConducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders
Goods and ServicesResearch, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing
Pseudo MarkCONQUERING CANCER THAT IS IN OUR DNA.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 7, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, July 7, 2014
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 7, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCTI BIOPHARMA CORP.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Party NameCTI BIOPHARMA CORP.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events


Event DateEvent Description
Tuesday, September 5, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 4, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2017EXTENSION 3 GRANTED
Tuesday, January 10, 2017EXTENSION 3 FILED
Tuesday, January 10, 2017TEAS EXTENSION RECEIVED
Tuesday, August 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 6, 2016EXTENSION 2 GRANTED
Friday, July 22, 2016EXTENSION 2 FILED
Friday, July 22, 2016TEAS EXTENSION RECEIVED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 18, 2016EXTENSION 1 GRANTED
Friday, January 8, 2016EXTENSION 1 FILED
Friday, February 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 8, 2016TEAS EXTENSION RECEIVED
Tuesday, August 4, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, May 2, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 2, 2015ASSIGNED TO LIE
Thursday, April 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 9, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, April 9, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 9, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, April 9, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, February 26, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 25, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 25, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 31, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NON-FINAL ACTION WRITTEN
Sunday, August 31, 2014ASSIGNED TO EXAMINER
Tuesday, July 8, 2014NOTICE OF PSEUDO MARK E-MAILED
Monday, July 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 4, 2014NEW APPLICATION ENTERED IN TRAM